You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • A rare population of tumor antigen-specific CD4+CD8+ double-positive αβ T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells

Article metrics

Article menu

Download PDFPDF

XML
Research Article
A rare population of tumor antigen-specific CD4+CD8+ double-positive αβ T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells

 

Online download statistics by month:

Online download statistics by month: December 2019 to January 2026

AbstractFullPdf
Dec 2019440
Jan 202087872
Feb 202086864
Mar 202046465
Apr 202031311
May 2020505022
Jun 202020202
Jul 202024241
Aug 202013132
Sep 202031313
Oct 2020414112
Nov 202028289
Dec 2020262615
Jan 2021353517
Feb 2021353516
Mar 2021424212
Apr 202113313320
May 202111011014
Jun 202111011013
Jul 2021999914
Aug 2021474712
Sep 2021757514
Oct 2021565632
Nov 2021414130
Dec 2021636315
Jan 2022555716
Feb 2022656712
Mar 2022434916
Apr 202235359
May 2022394023
Jun 2022192013
Jul 202252529
Aug 2022424411
Sep 2022424620
Oct 202228285
Nov 2022222524
Dec 202227275
Jan 202315157
Feb 202324255
Mar 202342437
Apr 2023242511
May 2023242410
Jun 202313145
Jul 2023303012
Aug 202324247
Sep 202316166
Oct 2023202011
Nov 202320264
Dec 2023434316
Jan 202489898
Feb 202430306
Mar 2024232358
Apr 2024282726
May 2024363617
Jun 2024303012
Jul 2024262715
Aug 2024303115
Sep 202421219
Oct 2024232317
Nov 2024333411
Dec 2024434513
Jan 2025262616
Feb 202513213214
Mar 2025333322
Apr 2025727216
May 2025343418
Jun 2025242412
Jan 2026210
Total28322866856